Oncoimmunology A Practical Guide for Cancer Immunotherapy /

In this book, leading experts in cancer immunotherapy join forces to provide a comprehensive guide that sets out the main principles of oncoimmunology and examines the latest advances and their implications for clinical practice, focusing in particular on drugs with FDA/EMA approvals and breakthroug...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Zitvogel, Laurence (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Kroemer, Guido (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2018.
Έκδοση:1st ed. 2018.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Fundamental bases: Immunology for the non immunologist: Cellular and molecular bases of cancer immunosurveillance
  • Innate immunity/NK in cancer immunosurveillance
  • Biology of regulatory T cells
  • Adenosine, P2R receptors.-Plasmacytoid DC dysfunctions in cancer
  • Chemotherapy and MDSC
  • Biology of Myeloid Derived Suppressor Cells
  • T cell fitness/polarization for antitumor immune responses
  • Tumor associated antigens and neoantigens
  • Tumor associated antigens and neoantigens
  • Immunization with peptides
  • Immunogenic cell death and chemotherapy
  • Breakthrough or advanced status of approaches: Cancer vaccines in HPV malignancies
  • Innate sensing of tumors and TLR agonists
  • DC-based cancer vaccines in melanoma
  • DC-based vaccines in breast cancer
  • T cell-based immunotherapies : CAR-T and TCR engineered T cells.-IDO and TDO-based inhibition in cancer. - FDA-EMA approval of I-O: Tumor-specific antibodies
  • Anti-CTLA4 Abs
  • Bispecific anti-CD3xCD19 antibodies
  • Combination of ICB in MM
  • Oncolytic viruses
  • Bacillus Calmette-Guérin and mycobacterial cell wall nucleic acid complexes in the treatment of non-muscle-invasive bladder cancer
  • The immunoscore
  • PDL-1 and other immunological diagnosis tools
  • Developping fields: The development of anti-41BB, Lag3, Anti-OX40, anti-ICOS, anti-GITR Ab
  • mRNA-based vaccination
  • Links between tumor genetics and immunotherapy
  • Local immunotherapies of cancer
  • Preventive DC-based cancer vaccines
  • Gut microbiota/oncomicrobiotics in cancer therapeutics
  • Strategies to reduce intratumoral Treg
  • Cold versus hot tumors
  • Immunopathology : an emerging field
  • Changes in Clinical Practice: Side effects of I-O
  • The clinical armamentarium in melanoma
  • The clinical armamentarium in kidney cancers
  • The clinical armamentarium in lung cancers
  • The clinical armamentarium in prostate cancers
  • Challenges of O-I for breast, ovarian, and non MSI colon cancers
  • Challenges in colon cancers
  • Current status of O-I in hematologic malignancies
  • Glioma and I-O
  • Assessing affinity and avidity of TCRs
  • Immunomonitoring studies.